What is Cadence?
Cadence is a specialized health technology firm headquartered in New York, dedicated to enabling large-scale health systems to provide high-quality care beyond traditional hospital settings. The company utilizes a sophisticated platform that aggregates and interprets patient vitals, employing machine learning to facilitate real-time, personalized responsiveness in disease management. By bridging the gap between clinical data and actionable insights, Cadence empowers providers to improve patient outcomes while optimizing operational efficiency. Its market position is defined by its ability to integrate seamlessly into existing health system workflows, addressing the growing demand for remote patient monitoring and proactive, data-driven healthcare solutions.
How much funding has Cadence raised?
Cadence has raised a total of $241.9M across 4 funding rounds:
Angel/Seed
$874K
Series A
$41M
Series B
$100M
Series C
$100M
Angel/Seed (2018): $874K, investors not publicly disclosed
Series A (2021): $41M led by Thrive Capital and General Catalyst
Series B (2021): $100M supported by Thrive Capital, Coatue, and General Catalyst
Series C (2026): $100M featuring Duke Health, Thrive Capital, Memorial Hermann, Spark Capital, Coatue, B Capital Group, Corewell Health Ventures, and General Catalyst
Key Investors in Cadence
General Catalyst
General Catalyst is a venture capital firm focused on supporting transformational business opportunities across multiple sectors, including healthcare and enterprise software, by providing strategic capital and operational expertise.
Thrive Capital
Thrive Capital is a New York-based venture capital firm that specializes in internet and software investments, providing critical backing to high-growth technology companies.
Coatue
Coatue Management is a prominent hedge fund sponsor and private equity investor that leverages deep market analysis to support companies at various stages of their growth trajectory.
What's next for Cadence?
With the successful closure of its latest funding round, Cadence is well-positioned to accelerate its product development and market penetration. The strategic nature of this investment suggests a focus on deepening partnerships with major health systems and enhancing the predictive capabilities of its machine learning engine. As the healthcare industry continues to shift toward value-based care models, Cadence is poised to play a pivotal role in defining the future of remote patient management. The company will likely prioritize scaling its infrastructure to support a broader patient base while maintaining the high standards of clinical responsiveness that have become its hallmark.
See full Cadence company page
